Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Oleptiss 180mg Tablet DT

Prescription Icon
Prescription Required

Marketer

Novartis India Ltd

Salt Composition

Deferasirox (180mg)

Overview Oleptiss 180mg Tablet DT

Ferroxamine 180mg delayed-release tablets treat chronic iron excess from repeated blood transfusions. This medication facilitates iron excretion, mitigating potential organ damage. Administer Ferroxamine 180mg on an empty stomach, adhering strictly to the prescribed dosage and schedule for optimal efficacy. Commonly reported side effects include nausea, headache, constipation, and diarrhea. Should these effects intensify or linger, consult your physician. Prior to commencing treatment, disclose any pre-existing liver or kidney conditions, and provide a complete list of all concurrent medications to ensure treatment safety.

Uses of Oleptiss 180mg Tablet DT

Managing Excess Iron

Major Benefits of Oleptiss 180mg Tablet DT:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Dissolve the Oleptiss 180mg Tablet DT in water before consumption. Administer on an empty stomach.

Common Side effects of Oleptiss 180mg Tablet DT:

  • Nausea
  • Headache
  • Vomiting
  • Rash
  • Abdominal pain
  • Constipation
  • Itching
  • Abdominal distension
  • Diarrhea

How to use Oleptiss 180mg Tablet DT:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Dissolve the Oleptiss 180mg Tablet DT in water before consumption. Administer on an empty stomach.

How Oleptiss 180mg Tablet DT works:

Oleptiss 180mg Delayed-Release Tablets bind and eliminate surplus iron, primarily through fecal excretion. This mitigates the potential for organ injury.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Oleptiss 180mg Tablet DT may pose unknown risks. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Oleptiss 180mg DT tablets during pregnancy poses a confirmed risk to the fetus. While generally contraindicated, a physician might exceptionally prescribe it in life-threatening cases where potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Breastfeeding mothers can likely use Oleptiss 180mg DT tablets safely. Available human data indicate minimal infant risk associated with the medication.

DrivingDrivingUNSAFE

Taking an Oleptiss 180mg extended-release tablet might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Driving is inadvisable if these effects are experienced.

KidneyKidneyUNSAFE

The use of Oleptiss 180mg DT tablets is likely inadvisable for individuals with impaired kidney function and should be avoided. Medical advice is recommended.

LiverLiverCAUTION

Patients with liver impairment should use Oleptiss 180mg Tablet DT cautiously; dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Oleptiss 180mg Tablet DT :

Should you forget to take your Oleptiss 180mg Tablet DT, ingest it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, forgo the missed dose and resume your usual dosing regimen. Avoid doubling the prescribed dosage.

Facts to Know About Oleptiss 180mg Tablet DT

LabelValue
Chemical Type Benzoate-triazole hybrid
Developing Habits No.
Treatment Category KINSHIP

FAQs on Oleptiss 180mg Tablet DT

Oleptiss 180mg Delayed-Release Tablets treat iron overload in beta-thalassemia major patients resulting from frequent blood transfusions.
Oleptiss 180mg Delayed-Release Tablets eliminate excess iron from the bloodstream, facilitating its excretion in the stool.
Oleptiss 180mg Tablet DT
1,198
MRP 1,387
13% off